InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 149487

Monday, 12/09/2013 11:56:40 AM

Monday, December 09, 2013 11:56:40 AM

Post# of 346177
More signs from Calico...

We don’t know much yet about the initiative, dubbed Calico, but Page revealed in a blog post that it will receive funding from Google. Biotechnology mogul Arthur Levinson, 63, who sat on both Google and Apple’s boards and formerly served as the chief executive at Genentech, will lead Calico as its CEO. Levinson said he declined numerous high-profile CEO positions before agreeing to join Calico.

“This was just so out of the [blue] that I instantly got extremely excited about it,” Dr. Levinson said in a rare interview with the New York Times.

...well over a dozen academics reached out to ask how they could get in touch with Levinson — we rarely see this level of interest for an early-stage venture.

http://medcitynews.com/2013/12/indicators-googles-calico-anti-aging-project-wont-pie-sky/
----------------------------------------------------

Dr. Robert Garnick.... CERTAINLY (imho) has talked to Art Levinson... I have a feeling we are all in for a little surprise on this front

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News